Utility of the methylated SEPT9 test for the early detection of colorectal cancer: a systematic review and meta-analysis of diagnostic test accuracy
Background Circulating tumour DNA from colorectal cancer (CRC) is a biomarker for early detection of the disease and therefore potentially useful for screening. One such biomarker is the methylated SEPT9 (mSEPT9) gene, which occurs during CRC tumourigenesis. This systematic review and meta-analysis...
Saved in:
Main Authors: | Rohit Hariharan, Mark Jenkins |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2020-12-01
|
Series: | BMJ Open Gastroenterology |
Online Access: | https://bmjopengastro.bmj.com/content/7/1/e000355.full |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Comparative analysis of SDC2 and SEPT9 methylation tests in the early detection of colorectal cancer: a systematic review and meta-analysis
by: Jie Zhang, et al.
Published: (2024-12-01) -
Methylated SEPTIN9 plasma test for colorectal cancer detection may be applicable to Lynch syndrome
by: Maria Christensen, et al.
Published: (2019-08-01) -
Diagnostic value of methylated SEPT9 and RNF180 for gastric cancer in high-risk population: a multi-centre retrospective study in Yunnan, Southwest China
by: Ying Huang, et al.
Published: (2024-12-01) -
Sept 4.03
by: Jeffrey Filbert
Published: (2006-01-01) -
%diag_test: a generic SAS macro for evaluating diagnostic accuracy measures for multiple diagnostic tests
by: Jacques K. Muthusi, et al.
Published: (2025-01-01)